For instance, EPAC1 has been implicated in promoting cell migration and metastasis of melanoma (19), whereas genetic or pharmacological inhibition of EPAC1 has been reported to reduce metastasis of pancreatic cancer (20, 21). Here, RAPGEF3 is linked to pancreatic neoplasm.